NeoGenomics
311 hedge funds and large institutions have $5.03B invested in NeoGenomics in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 107 increasing their positions, 104 reducing their positions, and 51 closing their positions.
62% more call options, than puts
Call options by funds: $11M | Put options by funds: $6.77M
3% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 104
3% less capital invested
Capital invested by funds: $5.21B → $5.03B (-$182M)
1.37% less ownership
Funds ownership: 92.37% → 91% (-1.4%)
6% less funds holding
Funds holding: 332 → 311 (-21)
35% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 51
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$60.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$52.9M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$38.5M |
| 4 |
BWLSA
Blue Water Life Science Advisors
Larkspur,
California
|
+$31.1M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$28.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$34.6M |
| 2 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$17.4M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$14.6M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$13.8M |
| 5 |
FAM
Fred Alger Management
New York
|
-$9.7M |
NEO Hedge Fund Activity: Q2 2021 in Review
311 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q2 2021, worth a combined $5.03B — down 3.5% from $5.21B a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of NEO and 33 opened new positions — a net loss of 18 holders — while 104 trimmed existing stakes and 107 added.
The largest buyer was Avidity Partners Management, opening a new position worth an estimated $60.6M. The largest seller was Mirae Asset Global Investments, exiting entirely with an estimated $34.6M sold.
- 311 institutional investors held NeoGenomics (NEO) as of Q2 2021, down from 332 in Q1 2021.
- Funds reported $5.03B of NeoGenomics stock for Q2 2021, down 3.5% quarter-over-quarter.
- 33 funds opened new NeoGenomics positions in Q2 2021 and 51 closed out, a net change of -18 holders.
- The largest NeoGenomics buyer in Q2 2021 was Avidity Partners Management, an estimated $60.6M added.
- The largest NeoGenomics seller in Q2 2021 was Mirae Asset Global Investments, an estimated $34.6M sold.
Based on aggregated 13F filings for Q2 2021.